KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Change in Account Payables: 2017-2025

Historic Change in Account Payables for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to -$284,000.

  • Twist Bioscience's Change in Account Payables rose 94.18% to -$284,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year increase of 179.05%. This contributed to the annual value of $9.3 million for FY2025, which is 179.05% up from last year.
  • Latest data reveals that Twist Bioscience reported Change in Account Payables of -$284,000 as of Q3 2025, which was down 108.89% from $3.2 million recorded in Q2 2025.
  • In the past 5 years, Twist Bioscience's Change in Account Payables registered a high of $6.9 million during Q3 2022, and its lowest value of -$7.5 million during Q1 2023.
  • In the last 3 years, Twist Bioscience's Change in Account Payables had a median value of -$284,000 in 2025 and averaged -$751,182.
  • Per our database at Business Quant, Twist Bioscience's Change in Account Payables skyrocketed by 65,740.00% in 2022 and then tumbled by 889.83% in 2023.
  • Twist Bioscience's Change in Account Payables (Quarterly) stood at -$5,000 in 2021, then spiked by 65,740.00% to $3.3 million in 2022, then plummeted by 228.12% to -$4.2 million in 2023, then spiked by 235.81% to $5.7 million in 2024, then surged by 94.18% to -$284,000 in 2025.
  • Its last three reported values are -$284,000 in Q3 2025, $3.2 million for Q2 2025, and $711,000 during Q1 2025.